Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Fix Price reported for 9 months of 2023

10/31/23 FIXP

Rosseti Siberia reported for 9 months of 2023 by RAS

10/31/23 MRKS

Arsagera reported for 9 months of 2023 by RAS

10/31/23 ARSA

Kamchatskenergo reported for 9 months of 2023 by RAS

10/31/23 KCHE

Sistema reported for 9 months of 2023 by RAS

10/31/23 AFKS

Polymetal narrowed the gap between production and sales

10/31/23 POLY

Mechel reported for 9 months of 2023 by RAS

10/31/23 MTLR

Globaltrack reported for 9 months of 2023 by RAS

10/30/23 GTRK

Rusolovo reported for 9 months of 2023 by RAS

10/30/23 ROLO

IMCB reported for 9 months of 2023 by RAS

10/30/23 GEMA